We use cookies to personalise content, analyse traffic and provide adverts via a third party. For more information on how we use cookies read our cookie policy in full.
You can change your cookie settings at any time, but parts of our site will not function correctly without them. Learn more about cookies.

• Avoid Streaksai (STK) by Steve Moore in ShareProphets
• Buy Ariana Resources (AAU) by Nigel Somerville in ShareProphets
• Avoid Microlise Group (SAAS) by Steve Moore in ShareProphets
• Equal Weight Standard Chartered (STAN) by Barclays
• Avoid Celadon Pharmaceuticals (CEL) by Tom Winnifrith in ShareProphets
• Buy Diploma (DPLM) by Stephen Wright in The Motley Fool
• Avoid Judges Scientific (JDG) by Steve Moore in ShareProphets
• Buy British American Tobacco (BATS) by Simon Watkins in The Motley Fool
• Buy BP (BP.) by Harvey Jones in The Motley Fool
• Buy Legal & General Group (LGEN) by Harvey Jones in The Motley Fool
• Neutral Smith (DS) (SMDS) by Davy
• Buy Genuit Group (GEN) by Jefferies
• Neutral Genuit Group (GEN) by JP Morgan
• Hold Ashmore Group (ASHM) by Deutsche Bank
• Buy IQE (IQE) by Deutsche Bank
• Hold FDM Group (Holdings) (FDM) by Deutsche Bank
• Buy Vodafone Group (VOD) by Simon Watkins in The Motley Fool
• Sector Perform Tesco (TSCO) by RBC Capital
• Outperform Sainsbury (J) (SBRY) by RBC Capital
• Hold Nichols (NICL) by Russ Mould in The Telegraph - Questor